BioNTech CEO Uğur Şahin disposes of USD 6,090,748 in common shares
BNTX•BioNTech CEO Uğur Şahin sold 61,000 ordinary shares from Sept. 25-28 at prices of USD 98.4682 to USD 98.6882 per share, leaving him with 280,209 directly held shares.
1. Share sales
Filings show that Şahin sold 61,000 BioNTech ordinary shares from Sept. 25-28, at prices ranging from USD 98.4682 to USD 98.6882 per share. His directly held stake fell to 280,209 shares after the transactions, which were executed under a Rule 10b5-1 trading plan adopted June 3, 2026.
